Participate in a clinical study of THCv to understand the effective dose for consumer products that are well tolerated.
Purpose: to evaluate the safety and tolerability of an investigational product CHI-915 for consumer use that is well tolerated.
Participation in the study requires an overnight stay in the Nucleus Network Clinic.
Overnight stays: 6 x 1 night stays
This study has been approved by an independent ethics committee.
Reimbursement for study participation will be provided for time and travel of up to $2,537.50 .
Call Gigi at 651-724-7832 or register your interest to discuss your eligibility today!